CBLN1 and acute myeloid leukemia: Mitophagy has been reported to be involved in the inhibitory effect of Crenolanib, an FLT3 inhibitor, inducing Cer accumulation and subsequently promoting cell death in FLT3-mutated AML cells [198,199].